Plasma osteopontin levels in prediction of prognosis in acute myocardial infarction

Acta Cardiologica

Volumn 66, Issue 2, 2011, Pages 197-202

  Okyay, Kaan ^a   Tavil, Yusuf ^a   Sahinarslan, Asife ^a   Tacoy, Gulten ^a   Turfan, Murat ^a   Sen, Nihat ^a   Gurbahar, Ozlem ^b   Boyaci, Bulent ^a   Yalcin, Ridvan ^a   Demirkan, Deniz ^a   Cengel, Atiye ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Department of Medical Biochemistry ^*  (Turkey)

Author keywords

Acute myocardial infarction; Osteopontin; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE MB; OSTEOPONTIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART PERFUSION; HUMAN; LEUKOCYTE COUNT; MAJOR ADVERSE CARDIOVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OSTEOPONTIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TROPONIN I;

EID: 79955777065     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.66.2.2071251     Document Type: Article

References (28)

1. Davies MJ. Stability and instability: the two faces of coronary atherosclerosis. Circulation 1996; 94: 2013-20.
2. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
3. Kristensen SD, Ravn HB, Falk E. Insights into the pathology of unstable coronary artery disease. Am J Cardiol 1997; 80: 5E-9E.
4. Buja LM, Willerson TJ. Role of inflammation in coronary artery plaque disruption. Circulation 1994; 89: 503-5.
5. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493-503.
6. Lendon CL, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991; 87: 87-90.
7. Moreno PR, Falk E, Palacious IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implicatons for plaque rupture. Circulation 1994; 90: 775-8.
8. Denhardt DT, Guo X. Ostepontin: a protein with diverse functions. FASEB J 1993; 7: 1475-82.
9. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000; 19: 615-22.
10. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998; 152: 353-8.
11. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860-4.
12. O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T-cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 2000; 68: 495-502.
13. Giachelli CM, Schwartzs SM, Liaw L. Molecular and cellular biology of osteopontin. Trends Cardiovasc Med 1995; 3: 88-95.
14. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with enviromental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-61.
15. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-7.
16. Coskun S, Atalar E, Ozturk E, Yavuz B, Ozer N, Goker H, Ovünç K, Aksöyek S, Kes S, Sivri B, Kirazli S, Ozmen F. Plasma Osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J Natl Med Assoc 2006; 98: 1746-50.
17. Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006; 27: 802-7.
18. Suezawa C, Kusachi S, Murakami T, Toeda K, Hirohata S, Nakamura K, Yamamoto K, Koten K, Miyoshi T, Shiratori Y. Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: Correlation with left-ventricular volume and function. J Lab Clin Med 2005; 145: 33-40.
19. Inoue T, Sakuma M, Yaguchi I, Mizoguchi K, Uchida T, Takayanagi K, Hayashi T, Morooka S. Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J 2002; 143: 790-6.
20. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, Singh K. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 2001; 88: 1080-7.
21. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
22. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 1993; 13: 120-25.
23. Rollo EE, Laskin DL, Denhardt DT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macro phages. J Leukoc Biol 1996; 60: 397-404.
24. Murry CE, Giachelli CM, Schwartz SM, Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 1994; 145: 1450-62.
25. Komatsubara I, Murakami T, Kusachi S, Nakamura K, Hirohata S, Hayashi J, Takemoto S, Suezawa C, Ninomiya Y, Shiratori Y. Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimantally induced myocardial infarction in rats. Cardiovasc Pathol 2003; 12: 186-94.
26. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, Tamura K, Saito Y, Mori S. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1999; 258: 722-6.
27. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 624-8.
28. Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F, Wollert-Wulf B, Fleck E, Graf K. Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 2002; 4: 139-46.